�鶹��ýӰ��

Meeting Coverage >

AAIC

Low Amyloid Burden Bodes Well for Future Dementia Risk

A ray of hope amidst disappointing results from A4 trial

Persistent Olfactory Loss After COVID Predicts Cognitive Impairment

Loss of smell a better predictor than severity of infection among older adults

Intensity of Football Head Impacts Linked With CTE Risk

Cumulative number and force of hits may be factors

Black, Hispanic Dementia Patients Less Likely to Choose Hospice at End of Life

These groups also incur more inpatient costs compared with white patients

Alzheimer's Researchers Delve Into Data From Failed Crenezumab Trial

Anti-amyloid agent missed primary endpoints, though small numeric differences favored the drug

Alzheimer's Blood Tests: Not Ready for Primary Care

But some biomarkers may revolutionize Alzheimer's diagnosis in the future

Hypertensive Disorders in Pregnancy Linked to Dementia Later in Life

Women saw higher risks of all-cause dementia and vascular dementia

Regular Exercise Program May Stall Cognitive Decline

Trial shows promise for people with mild cognitive impairment

Racism Experiences Tied to Worse Cognition

Links between racism and memory seen in both midlife and old age

ICU Stay Doubles Dementia Risk

Higher risks of both Alzheimer's and all-type dementia seen

Biomarkers Show Who Faces Near-Term Cognitive Decline

Consistent findings emerge in four groups of cognitively normal adults

Driving Patterns Pinpoint Early Alzheimer's Disease

Subtle shifts in on-road behavior suggest GPS-based biomarkers may have merit

COVID-19: Persistent Cognitive Effects, Uptick in Alzheimer's Biomarkers

Findings link cognitive impairment and long-lasting anosmia

Aducanumab: What to Know If You Prescribe

Recommendations may change when trial data are published

Better Air, Better Brains

Reducing air pollution tied to lower dementia risk, slower cognitive decline

Lifestyle, Policy Changes Could Make Big Dent in Dementia Burden

Report identifies 12 modifiable risk factors

Alzheimer's Blood Test Shows Same Accuracy as Imaging Markers

p-tau217 may be "a real game changer"

Infections Tied to Increased Mortality in Dementia Patients

Death rates higher even 10 years later, Danish study shows

Flu, Pneumonia Vaccines Tied to Lower Alzheimer's Risk

Older adults vaccinated against pneumonia have nearly 40% less Alzheimer's risk later in life

Alzheimer's Insulin Study Puzzles Researchers

Open-label extension shows a prolonged positive effect on cognition, but only in a subset

Does Alzheimer's Disease Stem From Infection?

Scientists debate, and one company targets gingivitis bacterium to slow Alzheimer's progression

Gut-Liver-Brain Interactions Tied to Alzheimer’s

Studies may explain mixed results of omega-3 trials

Tight BP Control Lowers Risk for Mild Cognitive Impairment

Data came from controversial SPRINT trial

Anti-Amyloid Drug Slows Cognitive Decline in Mid-Stage Trial

But will findings be replicated in phase III studies?

Tailored Lighting Improves Alzheimer's Patients Sleep, Mood

Exposure to specific light helped regulate circadian rhythms

Nabilone Effective for Easing Agitation in Alzheimer's

Cognition, neuropsychiatric symptoms also improved with synthetic cannabinoid

Women's Reproductive History Tied to Dementia Risk

Fewer children, miscarriages tied to increased risk

Alzheimer's Guidelines for Primary Care Announced

Take concerns seriously, communicate results clearly, guidelines recommend

Speech Changes May Signal Cognitive Impairment

Prospective study suggests 'connected speech' assessment could be screening tool

Lifetime Stress May Boost Dementia Risk for Blacks

African Americans seem to experience cognitive issues earlier

Watch Out for Brain Game Claims

Study wasn't powered to detect dementia outcomes

Donepezil Add-On Promising in Completer Analysis

Serotonin modulator slows but doesn't stop cognitive decline in phase II re-analysis.

Agent Orange Plus PTSD Equals Extra Dementia Risk

For Vietnam vets, defoliant exposure "may exacerbate effects of other risk factors."

T1D Patients Face Nearly Double Risk for Dementia

Findings still significant after controlling for vascular risk factors.

Anti-Amyloid Drug Has Mixed Results

COPENHAGEN -- The amyloid plaque-busting drug crenezumab for Alzheimer's disease slowed cognitive decline in patients with mild baseline impairment but missed its primary endpoint in a phase II trial.

HTN May Halt Dementia in Very Elderly

COPENHAGEN -- Among individuals who developed hypertension at age 90 or later, their risk of also developing dementia was dramatically lower than other very elderly people whose blood pressure remained normal.